Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danazol Pre-treatment for IVF in Endometriosis
NCT01779232Phase 4Completed
- Sponsor
- Centre for Endocrinology and Reproductive Medicine
- Start
- Oct 2012
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of danazol in endometriosis (2 arms), sponsored by Centre for Endocrinology and Reproductive Medicine. Primary endpoint: Pregnancy rate at 12 months. Started Oct 2012; status: completed.
02
Drugs
danazol
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT01779232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01779232.